Adisseo Appoints Li Bo as New Chairman and CEO

Animal nutrition company Adisseo has appointed Li Bo as chairman of its Board of Directors and chief executive officer, succeeding Dr. Hao Zhigang, according to an announcement published on 21 September 2026.

Li was elected chairman on 11 September 2026 and will take over as CEO effective 1 November 2026, at which point he will lead Adisseo's strategy and Executive Leadership Team.

Li most recently served as chairman and president of China National Bluestar, Adisseo's majority shareholder. He holds a master's degree in chemical engineering and an Executive MBA, and brings executive leadership experience in the energy and chemicals sectors.

In a statement, outgoing CEO Hao Zhigang expressed confidence in his successor. "It has been a privilege to lead Adisseo through an important period of transformation and growth. I am confident that Li Bo's leadership, experience, and vision will enable the company to build on its achievements and seize the opportunities ahead," Hao said.

Li outlined three strategic priorities for his tenure: maintaining Adisseo's leadership in methionine, strengthening its Specialties business as a growth pillar, and transforming its vitamin business. The company said it plans to continue strengthening its global competitiveness, operational performance, innovation, and sustainability efforts under the new leadership.

In his own statement, Li acknowledged the foundations laid by his predecessor and committed to advancing the company's stated mission. "I am honored to join Adisseo at this important moment in its development. Under Zhigang's leadership, the company has built a strong platform, a clear strategic direction, and a world-class team," Li said.